Eichler, Sarah
Herrmann, Tobias
Weidlich-Wichmann, Uta
Vissiennon, Kodjo
Pollmann, Thorsten
Weller, Lisa
Pommerenke, Christopher
Kroll, Lars
Alix, Nicolas
Dietsch, Tanja
von Stillfried, Dominik
Carnarius, Sebastian
Article History
Received: 19 February 2024
Accepted: 12 September 2024
First Online: 17 September 2024
Declarations
:
: The study and protocol are developed according to the Declaration of Helsinki guidelines and Good Clinical Practice (International Conference of Harmonization). Informed consent will be obtained from the participants. Informed consent and participation are asked by the voicebot via telephone; the patients also have the possibility to reject participation. Callers are asked to participate in the intervention and potential non-statement is counted as “no”. Since callers are potential acute and emergency cases, we refrain from a question on data evaluation, because a further delay after the conclusion of the telephone call due to extensive clarification would be disproportionate and ethically unjustifiable.The study protocol was approved by the Ethics Committee of the Berlin Medical Association (Eth.-32/23, 09th November 2023) and registered at the German Clinical Trials Register (DRKS00031235, 10th November 2023); .
: Not applicable.
: The authors declare no competing interests.